Deutsche Bank raised the firm’s price target on Praxis Precision (PRAX) to $437 from $412 and keeps a Buy rating on the shares.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PRAX:
- Praxis Precision NDA for Ulixacaltamide in Essential Tremor
- Praxis Precision announces FDA acceptance of ulixacaltamide NDA
- Praxis Precision Medicines: Advancing CNS Pipeline and Near-Term Data Catalysts Support Buy Rating Despite Cash Burn
- Praxis Precision initiated with a Strong Buy at Raymond James
- 3 Best Stocks to Buy Today, 4/7/2026, According to Top Analysts